Yield10 Competitors

Stocks . USA . 
Stock . Yield10 Bioscience
YTEN Stock  USD 0  0  100.00%   
Yield10 Bioscience competes with KS AG, Intrepid Potash, Bioceres Crop, Itafos, and Verde Agritech; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Yield10 Bioscience competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Yield10 Bioscience to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Yield10 Bioscience Correlation with its peers.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Yield10 Bioscience competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Yield10 Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.00029.12
Details
Intrinsic
Valuation
LowRealHigh
0.040.7129.83
Details
Naive
Forecast
LowNextHigh
0.000031029.12
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.120.190.50
Details

Yield10 Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Yield10 Bioscience and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Yield10 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Yield10 Bioscience does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
YARIY
+ 0.84
KPLUY
YARIY
+ 0.8
IPI
AVD
+ 0.79
IPI
VNPKF
+ 0.7
MBCF
VNPKF
+ 0.66
KPLUY
AVD
+ 0.66
YARIY
  
High negative correlations   
LVRO
- 0.75
MBCF
LVRO
- 0.47
VNPKF
LVRO
- 0.47
BIOX
MBCF
- 0.44
CGA
VNPKF
- 0.4
CGA
BIOX
- 0.3
CGA

Risk-Adjusted Indicators

There is a big difference between Yield10 Stock performing well and Yield10 Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Yield10 Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KPLUY  1.80  0.13  0.04  0.47  1.91 
(2.36)
 6.91 
(3.59)
 11.37 
IPI  2.12  0.02 (0.03)(0.03) 2.40 
(2.41)
 4.29 
(3.69)
 14.45 
CGA  3.90  0.18  0.02  1.34  5.89 
(3.88)
 9.14 
(9.90)
 19.04 
BIOX  2.62  0.08  0.02  0.21  3.00 
(2.98)
 6.53 
(4.88)
 15.29 
MBCF  0.92  0.18  0.05  5.50  1.09 
(1.92)
 3.39 
(1.49)
 9.77 
VNPKF  5.56  0.76  0.07 (0.35) 6.15 
(8.47)
 12.50 
(12.00)
 52.39 
YARIY  1.15 (0.03) 0.00 (0.07) 0.00 
 0.00 
 2.65 
(2.07)
 7.15 
BHIL  7.75 (0.63) 0.00 (0.43) 0.00 
 0.00 
 12.55 
(11.90)
 153.37 
AVD  2.49  0.22  0.06  0.53  3.00 
(2.71)
 7.08 
(5.36)
 16.06 
LVRO  3.85  0.27  0.04  1.15  4.70 
(4.48)
 8.44 
(8.14)
 21.68 
All Fundamental Data

Yield10 Bioscience Competitive Analysis

The better you understand Yield10 Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Yield10 Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Yield10 Bioscience's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
YTEN KPLUY IPI CGA BIOX MBCF VNPKF YARIY BHIL AVD
 100.00 
 0 
Yield10
 1.85 
 7.14 
KPLUY
 3.02 
 26.29 
Intrepid
 1.02 
 1.98 
CGA
 2.14 
 6.85 
Bioceres
 0.00 
 1.36 
Itafos
 8.77 
 0.62 
Verde
 1.77 
 14.97 
Yara
 33.92 
 2.61 
Benson
 1.48 
 6.18 
American
Market Volatility
(90 Days Market Risk)
Out of control
Somewhat reliable
Not too volatile
Dangerous
Slightly risky
Risky
Out of control
Very steady
Abnormally volatile
Moderately volatile
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Very Weak
Weak
Weak
OK
Modest
Very Weak
Very Weak
Modest
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Dangerous
Low
Low
Low
Low
Very High
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Cautious Hold
Not Rated
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Current Ratio
6.58
1.73
4.03
1.43
1.34
2.23
1.57
1.61
3.92
1.88
Net Asset
3.91 M
8.74 B
768.47 M
163.25 M
850.63 M
633.85 M
41.4 M
17.27 B
274.76 M
767.55 M
Profit Margin
N/A
0.28
-0.21
-0.3
0.0055
0.19
0.28
0.12
-0.27
-0.0522
EBITDA
(14.13 M)
2.45 B
(2.52 M)
(25.8 M)
55.46 M
129.15 M
5.29 M
1.93 B
(54.27 M)
45.08 M
Operating Margin
-7.12
0.31
-0.016
-0.47
0.0432
0.32
0.33
0.16
-0.58
-0.17
Current Valuation
2.06 M
2.66 B
321.51 M
(9.66 M)
651.62 M
332.04 M
188.29 M
14.54 B
91 M
363.79 M
Price To Book
11.23
0.56
0.53
0.28
1.37
0.92
6.06
1.45
0.41
0.53
Retained Earnings
(414.15 M)
N/A
40.79 M
(144.92 M)
(10.66 M)
N/A
N/A
59.96 B
(523.79 M)
332.9 M
Current Asset
15.34 M
1.73 B
195.72 M
335.58 M
102.35 M
N/A
N/A
36.45 B
N/A
236.83 M
Five Year Return
N/A
2.44
N/A
N/A
N/A
N/A
N/A
4.15
N/A
0.43
Beta
1.43
1.02
2.19
0.59
0.47
-1.07
1.15
0.48
2.15
0.88
Number Of Employees
29
11.04 K
485
13
11
377
250
37
270
845
Shares Outstanding
692.68 K
382.8 M
13.23 M
14.79 M
60.45 M
188.77 M
52.59 M
509.45 M
6.11 M
28.79 M
Cash Flow From Operations
(10.07 M)
326.9 M
43.23 M
(9.87 M)
41.72 M
94.5 M
(1.68 M)
1.41 B
(73.13 M)
(58.75 M)
Annual Yield
N/A
0.009
N/A
N/A
N/A
N/A
N/A
0.0454
N/A
0.0198
Total Debt
3.21 M
1.08 B
2.19 M
10.29 M
270.95 M
187.01 M
3.08 M
3.09 B
145.83 M
162.09 M
Return On Equity
-15.08
0.27
-0.0615
-0.25
0.0111
0.66
0.56
0.35
-1.56
-0.0843
Z Score
N/A
2.4
N/A
N/A
N/A
0.6
50.4
7.2
N/A
N/A
Return On Asset
-1.78
0.11
-0.0025
-0.1
0.031
0.19
0.24
0.13
-0.17
-0.0023
Number Of Shares Shorted
60.7 K
N/A
296.9 K
52.91 K
584.33 K
N/A
N/A
N/A
67.74 K
1.13 M
Book Value Per Share
-9.71
17.03
56.52
6.77
4.92
1.18
0.94
16.86
4.51
11.46
Current Liabilities
3.91 M
800 M
39.14 M
48.3 M
111.06 M
N/A
N/A
17.58 B
N/A
76.28 M
Total Asset
3.91 M
8.74 B
768.47 M
163.25 M
850.63 M
633.85 M
41.4 M
17.27 B
274.76 M
767.55 M
Debt To Equity
0.28
0.17
0.002
0.05
1.07
0.99
0.22
0.52
0.72
0.33
Short Ratio
0.03
N/A
2.43
3.55
3.55
N/A
N/A
N/A
1.99
3.24
Target Price
2.5
N/A
21.0
11.0
11.88
3.0
N/A
N/A
0.3
14.0
Last Dividend Paid
N/A
0.2
N/A
N/A
N/A
N/A
N/A
5.58
N/A
0.03
Shares Owned By Institutions
0.03
0.007
51.68
0.09
22.82
1.26
1.04
0.01
18.06
77.45
Market Capitalization
345.46 K
4.35 B
358.59 M
29 M
422.87 M
228.77 M
260.33 M
11.58 B
24.15 M
175.32 M
Price To Earning
-3.19
1.73
1.71
1.3
513.33
12.87
17.96
15.32
N/A
44.2
Price To Earnings To Growth
N/A
8.64
0.34
N/A
3.65
N/A
N/A
N/A
N/A
2.27
Price To Sales
0.46
0.72
1.74
0.31
0.96
0.38
2.48
0.46
0.064
0.32
Net Income
(14.46 M)
2.98 B
(35.67 M)
(28.41 M)
6.26 M
51.03 M
3.52 M
739 M
(115.31 M)
7.52 M
Earnings Per Share
-20.14
4.2
-3.38
-2.15
0.02
0.59
0.33
4.02
-21.34
-1.04
Shares Owned By Insiders
17.54
N/A
23.0
44.8
46.79
67.82
23.37
N/A
40.06
9.31
Revenue
60 K
3.21 B
279.08 M
95.85 M
464.83 M
413.25 M
27.71 M
16.62 B
473.34 M
579.37 M
Working Capital
(3.46 M)
928 M
105.48 M
66.39 M
79.16 M
N/A
N/A
18.87 B
17 M
201.53 M
Cash And Equivalents
10.16 M
566 M
18.51 M
71.14 M
38.61 M
61.81 M
1.59 M
512 M
210.52 M
20.33 M
Cash Per Share
2.07
1.48
4.14
4.24
0.84
0.33
0.03
1.0
1.02
0.71
Gross Profit
(6.46 M)
667.8 M
31.82 M
21.92 M
176.09 M
136.88 M
20.58 M
6.55 B
17.53 M
152.11 M
Day Typical Price
0.002
7.14
26.42
1.95
6.93
1.36
0.63
14.95
2.61
6.15
Accumulation Distribution
N/A
N/A
0.0385
0.065
0.0435
N/A
0.0462
0.0053
0.28
0.0368
Market Facilitation Index
N/A
N/A
1.04
0.13
0.31
N/A
0.03
0.08
0.86
0.23
Daily Balance Of Power
9.2 T
9.2 T
(0.79)
0.1538
(0.48)
0.0
1.666667
(3.38)
(1.56)
0.3913
Period Momentum Indicator
0.001
0.13
(0.82)
0.02
(0.15)
N/A
0.05
(0.27)
(1.34)
0.09
Rate Of Daily Change
2.0
1.02
0.97
1.01
0.98
1.0
1.09
0.98
0.66
1.01
Day Median Price
0.002
7.14
26.49
1.94
6.97
1.36
0.64
14.94
2.61
6.14
Price Action Indicator
5.0E-4
0.065
(0.61)
0.055
(0.19)
N/A
0.01
(0.10)
(0.67)
0.09
Coefficient Of Variation
(4,963)
1596.11
19190.13
2733.71
2735.77
807.3
1297.22
(32,529)
(3,324)
1247.61
Mean Deviation
16.16
1.8
2.12
3.9
2.62
0.9186
5.56
1.15
7.75
2.49
Jensen Alpha
(0.22)
0.1323
0.0166
0.1751
0.0783
0.1809
0.7572
(0.03)
(0.63)
0.2229
Total Risk Alpha
(2.96)
(0.06)
(0.24)
(0.25)
(0.17)
0.0555
(0.05)
(0.14)
(1.98)
(0.02)
Sortino Ratio
N/A
0.039
(0.03)
0.0166
0.0154
0.0469
0.0652
N/A
N/A
0.0562
Downside Variance
N/A
4.89
6.37
48.86
10.06
5.95
74.99
N/A
N/A
11.13
Standard Deviation
28.87
2.63
2.95
5.32
3.49
1.56
8.34
1.53
17.61
3.32
Kurtosis
4.95
2.25
2.75
(0.37)
0.7567
4.77
4.04
0.9826
36.86
0.5289
Potential Upside
66.67
6.91
4.29
9.14
6.53
3.39
12.5
2.65
12.55
7.08
Treynor Ratio
0.1106
0.4684
(0.03)
1.34
0.2057
5.5
(0.35)
(0.07)
(0.43)
0.5279
Maximum Drawdown
182.33
11.37
14.45
19.04
15.29
9.77
52.39
7.15
153.37
16.06
Variance
833.76
6.94
8.7
28.3
12.18
2.43
69.59
2.36
310.2
11.03
Market Risk Adjusted Performance
0.1206
0.4784
(0.02)
1.35
0.2157
5.51
(0.34)
(0.06)
(0.42)
0.5379
Risk Adjusted Performance
(0.01)
0.0594
0.0115
0.0391
0.0383
0.1085
0.0737
0.002
(0.02)
0.0747
Skewness
0.7382
1.04
1.11
(0.39)
0.5944
(0.16)
1.02
(0.36)
5.34
0.2473
Semi Deviation
N/A
1.91
2.4
5.89
3.0
1.09
6.15
N/A
N/A
3.0
Information Ratio
(0.02)
0.0328
(0.02)
0.0218
0.014
0.0734
0.0677
(0.05)
(0.03)
0.0565
Value At Risk
(31.43)
(3.59)
(3.69)
(9.90)
(4.88)
(1.49)
(12.00)
(2.07)
(11.90)
(5.36)
Expected Short fall
N/A
(2.36)
(2.41)
(3.88)
(2.98)
(1.92)
(8.47)
N/A
N/A
(2.71)
Downside Deviation
N/A
2.21
2.52
6.99
3.17
2.44
8.66
N/A
N/A
3.34
Semi Variance
N/A
3.64
5.77
34.68
8.99
1.19
37.8
N/A
N/A
9.0

Yield10 Bioscience Competition Performance Charts

Five steps to successful analysis of Yield10 Bioscience Competition

Yield10 Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Yield10 Bioscience in relation to its competition. Yield10 Bioscience's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Yield10 Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Yield10 Bioscience's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Yield10 Bioscience, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Yield10 Bioscience position

In addition to having Yield10 Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run High Dividend Yield ETFs Thematic Idea Now

High Dividend Yield ETFs
High Dividend Yield ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Dividend Yield ETFs theme has 112 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Dividend Yield ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:
How To Invest In Yield10
Details
Is Yield10 Stock a good investment?
Details
What is Yield10 Bioscience's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Yield10 Bioscience Correlation with its peers.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY